While our findings contribute to the growing body of knowledge on DYRK3 in cancer, ongoing research is essential to fully comprehend its intricate functions, paving the way for targeted therapies and personalized treatment approaches in ovarian cancer. Here, DYRK3 is linked to ovarian carcinoma.